|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online December 3, 2002 as doi:10.1096/fj.02-0578fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Max-Delbrueck-Center for Molecular Medicine and
¶ Medical Faculty of the Free University of Berlin,
| Institute for Anatomy and
Franz-Volhard-Clinic, Humboldt University of Berlin, Berlin;
$ Gene Center, Ludwig-Maximilians-University, Munich, Germany; and Departments of
Medical Biochemistry and
Connective Tissue Biology, University of Aarhus; and
** Department of Pathology, Aarhus University Hospital, Aarhus, Denmark
2Correspondence: Max-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Strasse 10, D-13125 Berlin, Germany. E-mail: willnow{at}mdc-berlin.de
SPECIFIC AIMS
Megalin is an endocytic receptor in proximal tubular cells (PTC) that mediates cellular uptake of 25-OH vitamin D3 complexed with the vitamin D binding protein (DBP). The receptor is responsible for the renal uptake and activation of 25-OH vitamin D3 to 1,25-(OH)2 vitamin D3, a central step in vitamin D metabolism. Unfortunately, the perinatal lethality of the conventional megalin knockout mouse model precluded in-depth analysis of the significance of this receptor pathway for calcium homeostasis and bone turnover in vivo. We have generated a new mouse model with kidney-specific megalin gene defect with which to test the contribution of this receptor to renal physiology and bone metabolism.
PRINCIPAL FINDINGS
1. Generation of a mouse model with kidney-specific megalin gene defect
We introduced lox P recombination sites into the murine megalin gene and generated mice carrying the modified receptor gene through their germ line. Animals homozygous for the floxed megalin gene (megalinlox/lox) exhibited normal development and unimpaired viability. In parallel, we established a mouse model with renal expression of Cre recombinase (Cre) using a fragment of the human apolipoprotein (apo) E promoter to drive the Cre transgene (apoECre). We produced mice doubly transgenic for the floxed megalin gene and the Cre gene (megalinlox/lox; apoECre) by breeding of the individual lines. Cre-mediated inactivation of the megalin gene in (megalinlox/lox; apoECre) mice resulted in a 90% reduction in renal megalin expression as shown by Western blot and immunohistology. No decrease in megalin levels was observed in other tissues expressing the receptor.
2. Urinary excretion of DBP in (megalinlox/lox; apoECre) mice
Consistent with the loss of renal megalin expression, kidneys from (megalinlox/lox; apoECre) mice were unable to retrieve plasma proteins from the glomerular filtrate and excreted increased amounts of low molecular weight proteins into the urine (Fig. 1
A, lanes 4 and 5). Excreted proteins included ligands for the receptor such as DBP (Fig. 1B
). In contrast, urine samples from megalinlox/lox (lanes 6 and 7) and apoECre animals (lane 3) were indistinguishable from wild-type samples (lane 1).
|
3. Impaired vitamin D metabolism in (megalinlox/lox; apoECre) mice
When 125I-DBP was injected intravenously into megalinlox/lox and (megalinlox/lox; apoECre) animals, no difference in the plasma turnover of the carrier was observed. However, (megalinlox/lox; apoECre) animals exhibited a fivefold increase in the urinary excretion of DBP vs. controls. A similar finding was obtained when the turnover of 3H-25-OH vitamin D3/DBP complexes was analyzed. Approximately sixfold higher levels of the labeled vitamin were found in the urine of the receptor-deficient mice. These findings demonstrated that megalin does not affect plasma turnover of DBP but is essential to retrieve the fraction of 25-OH vitamin D3/DBP complexes that have filtered through the glomerulus. Consistent with this hypothesis, (megalinlox/lox; apoECre) mice excreted significant amounts of endogenous 25-OH vitamin D3 into their urine (10.9 nM/mM creatinine). Urinary loss of the metabolitecoincided with a 50% reduction in the plasma levels of 25-OH vitamin D3 and 1,25-(OH)2 vitamin D3. On a vitamin D-enriched diet, serum calcium levels were not significantly altered; on a vitamin D-deplete diet, however, the mice exhibited hypocalcemia.
4. (Megalinlox/lox; apoECre) mice suffer from true severe osteomalacia
Finally, we analyzed the consequences of renal megalin deficiency on bone metabolism. Some alterations in vertebral bodies were detected when megalinlox/lox and (megalinlox/lox; apoECre) mice on a normal diet were compared (Fig. 2
A, C, E). In (megalinlox/lox; apoECre) mice, the bones were characterized by an increase in resorptive cavities, indicating a state of high bone turnover. On a vitamin D-deficient chow, vertebrates from (megalinlox/lox; apoECre) mice revealed a highly irregular and unmineralized bone surface that was largely covered by osteoids (Fig. 2D, F
). No such changes were seen in megalinlox/lox animals in response to vitamin D depletion (Fig. 2B
). Using point counting, we quantified static and dynamic bone parameters in these mice. No differences in bone parameters between megalinlox/lox and (megalinlox/lox; apoECre) on a normal diet were detected. On a vitamin D-deplete diet, in contrast, total bone mineral content in femur and tibia of (megalinlox/lox; apoECre) animals was drastically reduced (29.5 mg) compared with the controls (50.4 mg). The animals exhibited a significant increase in osteoid surface, osteoid width, and osteoid volume and a concomitant decrease in the mineralizing bone surfaces. Such features are indicative of osteomalacia as a consequence of dietary vitamin depletion.
|
CONCLUSION
Renal uptake and activation of 25-OH vitamin D3 is a central regulatory step in vitamin D and bone metabolism, but the exact route that delivers the vitamin to PTC, the site of conversion, is controversial. We earlier demonstrated that the endocytic receptor megalin mediates cellular uptake of 25-OH vitamin D3 bound to its carrier DBP, suggesting a crucial role of this receptor pathway in vitamin D conversion. Unfortunately, the perinatal lethality of the conventional megalin gene knockout precluded us from testing this hypothesis in detail. We have now generated a new mouse model with renal-specific megalin gene defect using Cre recombinase. Animals with kidney-specific megalin deficiency were viable and fertile. Yet a lack of receptor expression in the kidney resulted in severe plasma vitamin D deficiency, hypocalcemia, and osteomalacia as a consequence of hypovitaminosis D. Remarkably, the same phenotype is seen in mice lacking DBP, establishing the functional relationship of both proteins in vitamin D homeostasis. In conclusion, our data provide crucial in vivo evidence that delivery of 25-OH vitamin D3 to the kidney involves glomerular filtration of 25-OH vitamin D3/DBP complexes, followed by megalin-mediated retrieval from the lumen of the proximal tubules (Fig. 3
). 25-OH Vitamin D3 metabolites internalized via this pathway are converted into 1,25-(OH)2 vitamin D3 and resecreted into the circulation where they serve a crucial role in regulation of the systemic calcium and bone metabolism.
|
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.02-0578fje; to cite this article, use FASEB J. (December 3, 2002) 10.1096/fj.02-0578fje ![]()
This article has been cited by other articles:
![]() |
L. Monnens and E. Levtchenko Evaluation of the proximal tubular function in hereditary renal Fanconi syndrome Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2719 - 2722. [Full Text] [PDF] |
||||
![]() |
F. Theilig, W. Kriz, T. Jerichow, P. Schrade, B. Hahnel, T. Willnow, M. Le Hir, and S. Bachmann Abrogation of Protein Uptake through Megalin-Deficient Proximal Tubules Does Not Safeguard against Tubulointerstitial Injury J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1824 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nielsen, P. J. Courtoy, C. Jacobsen, G. Dom, W. R. Lima, M. Jadot, T. E. Willnow, O. Devuyst, and E. I. Christensen Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells PNAS, March 27, 2007; 104(13): 5407 - 5412. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Birn The kidney in vitamin B12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins Am J Physiol Renal Physiol, July 1, 2006; 291(1): F22 - F36. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Anzenberger, N. Bit-Avragim, S. Rohr, F. Rudolph, B. Dehmel, T. E. Willnow, and S. Abdelilah-Seyfried Elucidation of megalin/LRP2-dependent endocytic transport processes in the larval zebrafish pronephros J. Cell Sci., May 15, 2006; 119(10): 2127 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hiroki, Y.-H. Song, S. A. Liebhaber, and N. E. Cooke The human vitamin D-binding protein gene contains locus control determinants sufficient for autonomous activation in hepatic chromatin. Nucleic Acids Res., January 1, 2006; 34(8): 2154 - 2165. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Faber, V. Hvidberg, S. K. Moestrup, B. Dahlback, and L. B. Nielsen Megalin Is a Receptor for Apolipoprotein M, and Kidney-Specific Megalin-Deficiency Confers Urinary Excretion of Apolipoprotein M Mol. Endocrinol., January 1, 2006; 20(1): 212 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Raila, T. E. Willnow, and F. J. Schweigert Megalin-Mediated Reuptake of Retinol in the Kidneys of Mice Is Essential for Vitamin A Homeostasis J. Nutr., November 1, 2005; 135(11): 2512 - 2516. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Jong, R. Barone, E. Krenning, B. Bernard, M. Melis, T. Visser, M. Gekle, T. E. Willnow, S. Walrand, F. Jamar, et al. Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide J. Nucl. Med., October 1, 2005; 46(10): 1696 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nagai, E. I. Christensen, S. M. Morris, T. E. Willnow, J. A. Cooper, and R. Nielsen Mutually dependent localization of megalin and Dab2 in the renal proximal tubule Am J Physiol Renal Physiol, September 1, 2005; 289(3): F569 - F576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamagata, K. Ozono, Y. Hashimoto, Y. Miyauchi, H. Kondou, and T. Michigami Intraperitoneal Administration of Recombinant Receptor-Associated Protein Causes Phosphaturia via an Alteration in Subcellular Distribution of the Renal Sodium Phosphate Co-Transporter J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2338 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spoelgen, A. Hammes, U. Anzenberger, D. Zechner, O. M. Andersen, B. Jerchow, and T. E. Willnow LRP2/megalin is required for patterning of the ventral telencephalon Development, January 15, 2005; 132(2): 405 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bachmann, U. Schlichting, B. Geist, K. Mutig, T. Petsch, D. Bacic, C. A. Wagner, B. Kaissling, J. Biber, H. Murer, et al. Kidney-Specific Inactivation of the Megalin Gene Impairs Trafficking of Renal Inorganic Sodium Phosphate Cotransporter (NaPi-IIa) J. Am. Soc. Nephrol., April 1, 2004; 15(4): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Brunskill Albumin Signals the Coming of Age of Proteinuric Nephropathy J. Am. Soc. Nephrol., February 1, 2004; 15(2): 504 - 505. [Full Text] [PDF] |
||||
![]() |
R. A. Bianco, H. L. Keen, J. L. Lavoie, and C. D. Sigmund Untraditional methods for targeting the kidney in transgenic mice Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1027 - F1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gburek, H. Birn, P. J. Verroust, B. Goj, C. Jacobsen, S. K. Moestrup, T. E. Willnow, and E. I. Christensen Renal uptake of myoglobin is mediated by the endocytic receptors megalin and cubilin Am J Physiol Renal Physiol, September 1, 2003; 285(3): F451 - F458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Frick and D. A. Bushinsky Molecular Mechanisms of Primary Hypercalciuria J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1082 - 1095. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |